FS KKR Capital FSK 深 滬
交易中 09-24 12:00:02 美东时间
11.075
-0.095
-0.85%
華盛通- 最 高11.22
- 今 開11.22
- 成交量 48.16万股
- 最 低 11.045
- 昨 收 11.17
- 總市值 306.05万
- 52周最高 14.46
- 市盈率 靜 281.81
- 換手率 0.17%
- 52周最低 8.72
- 委 比 42.86%
- 總股本 0.00亿
- 歷史最高 19.96
- 量 比 0.80
- 振 幅 1.57%
- 歷史最低 -9.32
- 每 手 1
- 風險率 1.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FS Specialty Lending Fund (FSSL) Declares Distribution for September 2026
PHILADELPHIA, Sept. 10, 2026 /PRNewswire/ -- The Board of Trustees of FS Specialty Lending Fund (the Fund) (NYSE: FSSL) today announced the monthly distribution for September 2026.The distri...
09-11 04:15
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
JP Morgan Maintains Neutral on FS KKR Capital, Raises Price Target to $11
JP Morgan analyst Richard Shane maintains FS KKR Capital (NYSE:FSK) with a Neutral and raises the price target from $9.5 to $11.
08-20 02:50
KKR & Co Inc Stock (KKR) Moved Down by 5.44% on Aug 17: Key Drivers Unveiled
• KKR faced intraday volatility and profit-taking following a strong multi-session rally. • The company reported $25.26 billion in annual revenue and solid fundamentals. • Analysts maintain Buy ratings with an average price target of $126.58.
08-17 19:15
问题贷款规模激增，私人信贷承压
压力正蔓延至各类私人信贷投资组合。部分规模最大的基金已计提资产减值，并对问题贷款发出警示，该行业正遭遇近十年来最严峻的考验。 英国媒体基于固收数据服务商...
08-17 14:06
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
FS Credit Opportunities Corp. (FSCO) Declares Distribution for August 2026
PHILADELPHIA, Aug. 11, 2026 /PRNewswire/ -- The Board of Directors of FS Credit Opportunities Corp. (the Fund) (NYSE: FSCO) today announced the monthly distribution for August 2026. The dist...
08-12 04:15
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
FS KKR Capital shares are trading higher after the company reported better-than-expected Q2 financial results.
FS KKR Capital shares are trading higher after the company reported better-than-expected Q2 financial results.
08-07 01:57
财报速睇 | FS KKR Capital 2026财年Q2营收2.90亿美元，同比下降27.1%；归母净利润亏损0.34亿美元，同比亏损缩窄83.7%
华盛资讯8月6日讯，FS KKR Capital公布2026财年Q2业绩，公司Q2营收2.90亿美元，同比下降27.1%，归母净利润亏损0.34亿美元，同比亏损缩窄83.7%。
08-06 19:32
